Growth Metrics

Bionano Genomics (BNGO) Total Current Liabilities (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Total Current Liabilities for 9 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 38.57% to $22.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Dec 2025, down 38.57% year-over-year, with the annual reading at $22.9 million for FY2025, 38.57% down from the prior year.
  • Total Current Liabilities hit $22.9 million in Q4 2025 for Bionano Genomics, roughly flat from $23.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $100.0 million in Q4 2023 to a low of $7.2 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $32.4 million across 5 years, with a median of $30.4 million in 2022.
  • Biggest five-year swings in Total Current Liabilities: tumbled 69.08% in 2021 and later skyrocketed 178.75% in 2023.
  • Year by year, Total Current Liabilities stood at $21.8 million in 2021, then surged by 64.3% to $35.9 million in 2022, then surged by 178.75% to $100.0 million in 2023, then crashed by 62.67% to $37.3 million in 2024, then crashed by 38.57% to $22.9 million in 2025.
  • Business Quant data shows Total Current Liabilities for BNGO at $22.9 million in Q4 2025, $23.0 million in Q3 2025, and $24.2 million in Q2 2025.